Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Blinder

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Clinical Pharmacy and Therapeutics|July 9, 2016
Combination therapy in relapsed or refractory chronic immune thrombocytopenia: a case report and literature reviewA Rashidi, M A Blinder
The Journal of Biological Chemistry|January 5, 1990
Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor IIM A Blinder, D M Tollefsen
CA: a Cancer Journal for Clinicians|May 1, 1983
Brain metastasis from esophageal carcinomaS D Averbuch, M A Blinder
British Journal of Haematology|April 1, 1997
Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorderN S Colwell, D M Tollefsen, M A Blinder
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapyJ J Field, T S Fenske, M A Blinder
The Journal of Biological Chemistry|April 5, 1990
Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibitionV M Derechin, M A Blinder, D M Tollefsen
The Journal of Biological Chemistry|March 25, 1989
Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfateM A Blinder, T R Andersson, U Abildgaard, et al.
Clinical Chemistry|November 4, 1998
HPLC detection of fetal blood in meconium: improved sensitivity compared with qualitative methodsD Chen, T R Wilhite, C H Smith, et al.
The Journal of Biological Chemistry|May 5, 1991
Role of lysine 173 in heparin binding to heparin cofactor IIH C Whinna, M A Blinder, M Szewczyk, et al.
American Journal of Clinical Pathology|July 9, 1999
Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rodsZ Kaleem, M S Watson, M M Zutter, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacy and Therapeutics|July 9, 2016
Combination therapy in relapsed or refractory chronic immune thrombocytopenia: a case report and literature reviewA Rashidi, M A Blinder
The Journal of Biological Chemistry|January 5, 1990
Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor IIM A Blinder, D M Tollefsen
CA: a Cancer Journal for Clinicians|May 1, 1983
Brain metastasis from esophageal carcinomaS D Averbuch, M A Blinder
British Journal of Haematology|April 1, 1997
Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorderN S Colwell, D M Tollefsen, M A Blinder
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 11, 2007
Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapyJ J Field, T S Fenske, M A Blinder
The Journal of Biological Chemistry|April 5, 1990
Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibitionV M Derechin, M A Blinder, D M Tollefsen
The Journal of Biological Chemistry|March 25, 1989
Heparin cofactor IIOslo. Mutation of Arg-189 to His decreases the affinity for dermatan sulfateM A Blinder, T R Andersson, U Abildgaard, et al.
Clinical Chemistry|November 4, 1998
HPLC detection of fetal blood in meconium: improved sensitivity compared with qualitative methodsD Chen, T R Wilhite, C H Smith, et al.
The Journal of Biological Chemistry|May 5, 1991
Role of lysine 173 in heparin binding to heparin cofactor IIH C Whinna, M A Blinder, M Szewczyk, et al.
American Journal of Clinical Pathology|July 9, 1999
Acute promyelocytic leukemia with additional chromosomal abnormalities and absence of Auer rodsZ Kaleem, M S Watson, M M Zutter, et al.
Pageof 2